Quantbot Technologies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Quantbot Technologies’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-155	Closed	-$8K	–	1840
2020 Q4	$8K	Buy	+155	New	+$9.19K	﹤0.01%	1127
2020 Q1	–	Sell	-500	Closed	-$31K	–	1500
2019 Q4	$31K	Sell	500 -3,700	-88%	-$176K	﹤0.01%	1010
2019 Q3	$142K	Buy	+4,200	New	+$124K	0.01%	758
2018 Q4	–	Sell	-153	Closed	-$5K	–	1494
2018 Q3	$5K	Sell	153 -2,124	-93%	-$78.5K	﹤0.01%	1198
2018 Q2	$89K	Buy	+2,277	New	+$67K	0.01%	893

Other funds holding DCPH

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 33.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quantbot Technologies's DCPH Position: Q1 2021 in Review

Quantbot Technologies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 155 shares — an estimated $8K sold.

Quantbot Technologies first reported a position in DCPH in Q2 2018 and held it in 5 quarters. The position peaked at $142K in Q3 2019. 168 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

Quantbot Technologies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Quantbot Technologies sold 155 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $8K.
Quantbot Technologies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
Quantbot Technologies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $142K in Q3 2019.
168 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Quantbot Technologies's 13F filing for Q1 2021, filed 14 May 2021.